Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU's MDR: When Three Plus Four Does Not Necessarily Make Seven

Executive Summary

Companies hoping to keep their medtech products certified under the current Medical Devices Directive on the market until May 2024 need a reality check, experts say. Things may not be as they seem.

You may also be interested in...



New EU Devices Regulation Lacking As A Safety And Effectiveness Check, German Study Claims

Even though the new EU Medical Device Regulation marks a “very important advancement,” it still falls short when it comes to requirements on generating clinical evidence, according to a study conducted in Germany.

EU's New Medical Device Regulation: A Timetable To Kickstart Planning

The EU's Medical Device and IVD Regulations are published in the Official Journal of the European Union, setting a series of deadlines for implementation and compliance. There is a lot to do in a relatively short amount of time. Here's a timetable of what to expect.

EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions

It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT105059

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel